PharmEng Nordic ApS: Financial statements 2024
CVR: 43181033
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PharmEng Nordic ApS (CVR 43181033) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 870,271 and a net result of DKK -876,098 compared with DKK -941,012 the year before. That is an increase of 49.2% compared with the year before. Equity in the 2024 report amounted to DKK -2,053,463. The company had 2 employees in the financial year.
- Gross Profit
- DKK 870,271
- Profit/Loss
- DKK -876,098
- Equity
- DKK -2,053,463
- Total Assets
- DKK 1,011,048
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 870K | -876K | -2.1M | 2 |
| 2023 | - | 583K | -941K | -1.2M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PharmEng Nordic ApS has published its annual report for 2023. Gross profit came to DKK 583,327, and the net result was DKK -941,012.
About PharmEng Nordic ApS
PharmEng Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Mathieu Charles Louis Roger, Olivier Claude Gillot and Olivier Tambuzzo. The company is owned by Efor Group SAS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 295,768 and a net result of DKK -1,108,665 compared with DKK -876,098 the year before. Equity in the 2025 report amounted to DKK -3,162,128.